Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.

ClinicalTrials.gov ID: NCT01146574

Public ClinicalTrials.gov record NCT01146574. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Multi-center, Randomized, Single Dose, Double-blind, Placebo-controlled Followed by a Multiple-dose, Single-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, Efficacy, Tolerability, and Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease (ESRD) on Hemodialysis (HD).

Study identification

NCT ID
NCT01146574
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celgene
Industry
Enrollment
50 participants

Conditions and interventions

Conditions

Interventions

  • Sotatercept Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2010
Primary completion
Mar 6, 2016
Completion
Mar 6, 2016
Last update posted
Feb 29, 2024

2010 – 2016

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
North American Research Institute Azusa California 91702-3439
West Glendale Dialysis Glendale California 91205
California Institute of Renal Research La Mesa California 91942
Academic Medical Center Los Angeles California 90022
Academic Medical Research Institute Los Angeles California 90022
Nephrology Specialist Medical Group Orange California 92868
Pines Clinical Research Inc. Pembroke Pines Florida 33028
University of Kentucky Lexington Kentucky 40536
Fresenius Medical Care North America MI Kalamazoo Michigan 49007
DaVita Clinical Research Minneapolis Minnesota 55404
Nephrology and Hypertension Associates, LTD Tupelo Mississippi 38801
St. Louis University Medical Center St Louis Missouri 63110
Washington University School of Medicine St Louis Missouri 63110
Kidney Specialists of Southen Nevada Las Vegas Nevada 89106
Brookview Hill Research Associates, LLC Winston-Salem North Carolina 27103
MetroHealth Medical Systems Cleveland Ohio 44109
Northeast Clinical Research Center Bethlehem Pennsylvania 18017
Nephrology Associates, PC Nashville Tennessee 37205
Corva Kidney Center Webster Houston Texas 77003
Beechnut Dialysis Center Houston Texas 77036
Miracle Medical Clinic Houston Texas 77055
Gessner Dialysis Center Houston Texas 77074
Tyler Nephrology Associates, PC Tyler Texas 75702
University of Virginia at University Ave. Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01146574, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 29, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01146574 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →